Cosmo Pharmaceuticals Announced FDA Has Approved TEVA's Generic Version Of Uceris, Actavis; Co. Says It Will Continue To Defend And Enforce Patent Rights On Uceris, Says If Teva Decides To Launch At Risk, It Would Expose Teva To Pay Significant Damages
Benzinga Newsdesk